Miller says not talking about the alternatives is actually a red flag: If your provider jumps to GLP-1s without discussing other strategies, they may be skipping crucial steps in your care plan. 8
Rare but Serious Risks In rare cases, side effects such as pancreatitis or allergic reactions may occur
The trial randomized a total of 792 participants, of whom 195 (25%) were female, and had a mean age of 66.6 years with a standard deviation of 9.4 years
These findings are particularly relevant for populations with dual burdens of obesity and nicotine dependence, suggesting that GLP-1 agonists could serve as a dual-purpose intervention
The people randomised were responders who had already tolerated dose escalation, so the results apply most directly to patients who have done reasonably well on treatment
Patients should be provided with written information and encouraged to report any concerns promptly